Aclaris Therapeutics (ACRS)
NASDAQ:ACRS
US Market
Advertisement

Aclaris Therapeutics (ACRS) Technical Analysis

Compare
859 Followers

Technical Sentiment

Overall Consensus
Strong Buy
16Bullish
6Neutral
0Bearish
Technical Analysis Consensus
Buy
4Bullish
6Neutral
0Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Aclaris Therapeutics’s (ACRS) Moving Averages Convergence Divergence (MACD) indicator is 0.09, suggesting Aclaris Therapeutics is a Buy.
Aclaris Therapeutics’s (ACRS) 20-Day exponential moving average is 2.26, while Aclaris Therapeutics’s (ACRS) share price is $2.41, making it a Buy.
Aclaris Therapeutics’s (ACRS) 50-Day exponential moving average is 2.09, while Aclaris Therapeutics’s (ACRS) share price is $2.41, making it a Buy.

Aclaris Therapeutics (ACRS) Pivot Points

Nov 14, 2025, 09:38 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.91
2.01
2.15
2.25
2.39
2.49
2.63
Fibonacci
2.01
2.10
2.15
2.25
2.34
2.39
2.49
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aclaris Therapeutics (ACRS) Moving Averages

Nov 14, 2025, 09:38 AM
Period
Simple
Exponential
MA5
2.29Buy
2.32Buy
MA10
2.36Buy
2.31Buy
MA20
2.29Buy
2.26Buy
MA50
2.07Buy
2.09Buy
MA100
1.86Buy
1.97Buy
MA200
1.74Buy
2.02Buy
Aclaris Therapeutics’s (ACRS) 10-Day exponential moving average is 2.31, while Aclaris Therapeutics’s (ACRS) share price is $2.41, making it a Buy.
Aclaris Therapeutics’s (ACRS) 100-Day exponential moving average is 1.97, while Aclaris Therapeutics’s (ACRS) share price is $2.41, making it a Buy.
Aclaris Therapeutics’s (ACRS) stock price is $2.41 and Aclaris Therapeutics’s (ACRS) 50-day simple moving average is 2.07, creating a Buy signal.
Aclaris Therapeutics’s (ACRS) stock price is $2.41 and Aclaris Therapeutics’s (ACRS) 100-day simple moving average is 1.86, creating a Buy signal.
Aclaris Therapeutics’s (ACRS) stock price is $2.41 and Aclaris Therapeutics’s (ACRS) 200-day simple moving average is 1.74, creating a Buy signal.

Aclaris Therapeutics (ACRS) Technical Indicators

Nov 14, 2025, 09:38 AM
Name
Value
Implied Action
RSI (14)
57.59
Neutral
STOCH (9,6)
28.91
Neutral
STOCHRSI (14)
30.58
Neutral
MACD (12,26)
0.09
Buy
ADX (14)
31.38
Neutral
Williams %R
-47.93
Buy
CCI (14)
47.42
Neutral
ATR (14)
0.22
-
Ultimate Oscillator
44.48
Neutral
ROC
6.64
Buy
Aclaris Therapeutics’s (ACRS) Relative Strength Index (RSI) is 57.59, creating a Neutral signal.
Aclaris Therapeutics’s (ACRS) Trend Strength Indicator (ADX) is 31.38, creating a Neutral signal.
Aclaris Therapeutics’s (ACRS) Commodity Channel Index (CCI) is 47.42, creating a Neutral signal.
Aclaris Therapeutics’s (ACRS) Price Rate of Change (ROC) is 6.64, creating a Buy signal.

FAQ

Is ACRS a Buy, Hold, or Sell?
Based on ACRS’s technical indicators, ACRS is a Strong Buy.
    What is ACRS’s RSI (14)?
    ACRS’s RSI (14) is 57.59, which suggests ACRS is a Neutral.
      What is ACRS’s MACD?
      ACRS’s MACD is 0.09, which suggests ACRS is a Buy.
        What is ACRS’s 5-day moving average?
        ACRS’s 5-day moving average is 2.29, which suggests ACRS is a Buy.
          What is ACRS’s 20-day moving average?
          ACRS 20-day moving average is 2.29, which suggests ACRS is a Buy.
            What is ACRS’s 50-day moving average?
            ACRS’s 50-day moving average is 2.07, which suggests ACRS is a Buy.
              What is ACRS’s 200-day moving average?
              ACRS’s 200-day moving average is 1.74, which suggests ACRS is a Buy.
                What is ACRS’s Williams % R (14)?
                ACRS’s Williams % R (14) is -47.93, which suggests ACRS is a Buy.
                  What is ACRS’s CCI (14)?
                  ACRS’s CCI (14) is 47.42, which suggests ACRS is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis